Søren Skov Jensen, M.Sc., PhD, serves as Associate Director, Analytical Development at Hemab. He has over 13 years of experience in the biotechnology industry and has worked on therapeutics ranging from peptides to proteins and monoclonal antibodies across early- and late-stage development. Most recently, Søren worked as a CMC Submission Expert at Novo Nordisk, where he was involved in preparing submission documents for antibody-based therapeutics. Prior to that, he was a senior specialist in product characterization at Genmab where he was involved in the submission and approval by EMA and FDA of two antibody-based therapeutics. Søren holds a PhD in Biochemistry and Molecular Biology from the University of Southern Denmark.